We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease. For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W
View Top Employees from MyoKardiaWebsite | http://www.bms.com |
Ticker | MYOK |
Revenue | $70 million |
Funding | $797.6 million |
Employees | 45 (45 on RocketReach) |
Founded | 2012 |
Address | 1000 Sierra Point Parkway, Brisbane, California 94005, US |
Phone | (650) 741-0900 |
Technologies |
JavaScript,
HTML,
Twitter
+69 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Drug Discovery, Genetic Heart Disease, Pharmaceuticals, Biotechnology, Cardiomyopathy, Healthcare, Medical Testing & Clinical Laboratories |
Competitors | Magenta Therapeutics, Otonomy, Inc, Sage Therapeutics, Visterra Inc., Xenon Pharmaceuticals Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular MyoKardia employee's phone or email?
The MyoKardia annual revenue was $70 million in 2024.
Willem van Weperen is the Senior Vice President Head of Europe of MyoKardia.
45 people are employed at MyoKardia.
MyoKardia is based in Brisbane, California.
The NAICS codes for MyoKardia are [3254, 32541, 32, 325].
The SIC codes for MyoKardia are [283, 28].